Status:
UNKNOWN
Evaluate Safety & Efficacy of Condroflex in Subjects With OA
Lead Sponsor:
Zodiac Produtos Farmaceuticos S.A.
Conditions:
Treatment
Osteoarthritis
Eligibility:
All Genders
40-70 years
Phase:
PHASE3
Brief Summary
Primary Objective: To compare, after 12 weeks of double-blind treatment, the evolution of the improvement of pain (at rest and during / after exercise) in the questionnaire WOMAC (Western Ontario and ...
Detailed Description
To have osteoarthritis degree 2 or 3 / To be capable to consent
Eligibility Criteria
Inclusion
- to have knee osteoarthritis degree 2 or 3
- to be capable to consent
Exclusion
- previous drug treatment
- concomitant diseases
- concomitant drugs
Key Trial Info
Start Date :
March 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2010
Estimated Enrollment :
240 Patients enrolled
Trial Details
Trial ID
NCT00838487
Start Date
March 1 2009
End Date
March 1 2010
Last Update
October 12 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CRDB
São Paulo, Brazil